Infections ( Alert Organisms And Conditions ) That Require Source Isolation - Protocol |
Publication: 01/05/2009 |
Next review: 04/08/2023 |
Clinical Protocol |
CURRENT |
ID: 1671 |
Approved By: Trust Clinical Guidelines Group |
Copyright© Leeds Teaching Hospitals NHS Trust 2020 |
This Clinical Protocol is intended for use by healthcare professionals within Leeds unless otherwise stated. |
Infections That Require Source Isolation Protocol
- Aims
- Background and indications protocol
- Routes and modes of transmission
- Precautions
- Table of infections: A - Z
- Appendix A - Definitions
- Appendix B - List of Other Organisms/Conditions That Pose a Risk to other in-patients at LTHT
- Appendix C - List of Groups Posing a Special Risk of Spreading Gastro-intestinal Infections
- Appendix D - Multi Drug Resistant Micro-organisms
- Appendix E - Communicable Notifiable Diseases
- Appendix F - Danger of Infection Samples
This protocol provides information on those patients who are diagnosed with an infection, or are identified as colonised, with micro-organisms that are easily transmitted to other people and constitute an infection risk to other patients, staff or visitors. This protocol also specifies the Infection Prevention and Control (IPC) actions that are required when a patient is diagnosed, or identified as colonised with, a specific organism or condition, as detailed in the list below. It should be used in conjunction with other relevant LTHT Infection Prevention and Control Policies and Guidelines.
Aims
- To prevent and control the spread of communicable infections within LTHT
- To promote a safe environment for all patients within LTHT
- To provide the information required to ensure that appropriate IPC measures are applied when patients are found to be colonised by, or infected with, micro-organisms that are either easily transmitted and/or associated with potentially significant implications if acquired by someone else
Background and indications protocol
A requirement for source isolation may be suggested by a clinical presentation e.g. diarrhoea / vomiting with unknown cause or a positive microbiological result. Source isolation must be carried out according to the Isolation guidelines.
If source isolation is not possible, the clinical team should contact the IPCT (in hours) or the Clinical Site Manager should contact the on call Consultant Microbiologist (out of hours), with the required patient information for a risk assessment to be completed
There are certain transmissible micro-organisms that are of a rare incidence within the United Kingdom (see Appendix F). If an organism within this category is suspected or identified the IPCT (in hours) or the Consultant Microbiologist on call (out of hours) should be contacted immediately.
Routes and modes of transmission
Direct Contact
Transfer of micro-organisms from a colonised or infected person to a person who is not colonised or infected by direct physical contact.
Indirect Contact
Transfer of micro-organisms via a fomite (an inanimate object e.g. BP machine or ultrasound probe) or vector (human or animal).
Droplet
Transfer of micro-organisms by production and dissemination of large droplets e.g. by coughing or sneezing.
Airborne
Transfer of micro-organisms by production and dissemination of droplet nuclei (very small droplets), or dust particles or skin scales. The difference between Droplet and Airborne spread is subtle and depends on the fact that droplet nuclei and dust particles remain airborne for long periods of time.
Ingestion
Transfer of micro-organisms from a human, animal or environmental source by ingestion of food, water or other contaminated material. If the organism is subsequently excreted in faeces this constitutes the “faecal-oral” route of infection.
In practice multiple modes of transmission may apply to a single organism type e.g. norovirus may be transmitted by direct contact, indirect contact (via staff or objects), droplet spread (via projectile vomit) and faecal-oral (via diarrhoea), although the final acquisition is by ingestion.
(Control of Communicable Diseases Manual 20th Edition (2015))
Precautions
Standard Precautions - A risk assessment is required for all patient / environment contact regardless of infection status - see below.
No Risk of exposure to blood or bodily fluid |
No Protective Clothing |
Blood/body fluid - low risk of splash, (for example toileting a patient, removing or inserting a cannula). |
Disposable single use aprons and gloves |
Blood/body fluid - |
Disposable gloves/plastic aprons/eye protection/face masks/ water resistant gowns |
Hand hygiene precautions to be used in the care of all patients. |
Source Isolation Precautions - Disposable single use aprons and gloves as a minimum. A risk assessment as above is required for ‘high risk of splash’. All waste arising out of the isolation room/cohort area must be treated as infected, using an orange infectious waste bag even if it has not been used. Linen must be placed in an alginate bag inside a red laundry bag ( Refer to Isolation guideline). Hand hygiene should be performed prior to entering the room, before leaving the room and after exiting the room (Refer to Hand Hygiene Policy - LTHT). Sharps Bins (Orange & Yellow) required.
Enhanced (organism Specific) Precautions - See individual organism. These precautions must be undertaken in addition to the standard precautions indicated from the above assessment. IMPORTANT - you must adhere to the sample processing requirements defined in the below table (‘hazard group category column’) to ensure that samples can be processed safely in the lab and the risk of infection is adequately controlled).
Full relevant clinical details are required on request forms for Microbiology to allow the laboratory to fully assess the risk of isolating a HG3 pathogen from a sample, especially when a patient first attends for investigation and before anything has been isolated - see Appendix F for clinical details associated with increased risk of exposure.
Table of infections: A - Z
Infection (Alert Organism/ Condition) |
Source Isolation Required |
Mode of Transmission |
Duration of Isolation |
Precautions Required |
Hazard group (HG#) category(MUST detail in ‘clinical details’ field on request) & follow any additional instructions detailed below |
Acinetobacter baumanni For screening and source isolation requirements for potential carbapenemase-producing organisms Carbapenemase-Producing Enterobacteriaceae (CPE) For Neonates please see guideline:- Infections that require Source Isolation on the Neonatal Unit Protocol |
Yes |
Commonly found within the environment on both wet and dry surfaces (often found in dust). Transmission can occur via direct or indirect contact with contaminated surfaces or patient shared equipment. |
Duration of admission and all future admissions |
Source Isolation Precautions Enhanced precautions- If CPE positive: long sleeved gowns |
HG2 |
Anthrax All cases to be reported; Please contact IPC to discuss all suspected or confirmed cases Note: “Danger of infection” labelling required w.r.t sample submissions: |
No |
Animals infected shed the bacilli in haemorrhagic stage at death. Direct contact with tissues of infected animals or through the bites of insects who have fed on infected animals. Incubation period is 1- 12 days, although periods up to 60 days are possible. |
N/A |
Standard Precautions Enhanced precautions- FFP3 masks( if undertaking aerosol generating procedures) |
HG3 Note: “Danger of infection” labelling required w.r.t sample submissions: Samples must be hand delivered and clearly document the hazard group category in the clinical details field. |
Bacillus cereus (only if associated with food poisoning). Further information:- |
No |
This is a common organism found in the soil, the environment and also found at low levels in raw, dried and processed foods. Ingestion of contaminated foods and cooked foods left at ambient temperatures. Incubation 0.5 to 6 hours in cases where vomiting is the predominant symptom. Diarrhoea predominates 6-24 hours after. |
N/A |
Standard Precautions LTHT workers to contact Occupational Health for advice |
HG2 |
Body Lice (Pediculus corporis) and Crab Lice (Phthirus pubis) |
No; however for patient privacy and dignity whilst undergoing treatment placement in a side room is recommended. |
Direct contact with an infested person or by indirect contact with personal belongings e.g. clothing. P. pubis by sexual contact Life cycle involves 3 stages; eggs, nymphs and adults. Life cycle is similar to that of head lice. A person will remain an infectious source as long as lice or eggs remain alive on an infested person or fomite |
N/A |
Standard Precautions |
N/A |
Brucella spp. NOTIFIABLE DISEASE Note: “Danger of infection” labelling required w.r.t sample submissions: |
No. |
Contact through breaks in the skin with infected animal tissues, blood and body fluids, ingestion of unpasturised milk or cheeses from infected animals. Incubation is variable and difficult to ascertain (5-60 days). |
N/A |
Standard Precautions |
HG3 Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Campylobacter spp.
|
No |
Usually through ingestion of under cooked meats, poultry or contaminated food and water. Also through contact with infected pets (puppies and kittens), farm animals. Incubation period usually 2-5 days with a range of 1-10. The infective dose is usually low; person to person transmission is relativity uncommon |
N/A |
Standard Precautions LTHT workers to contact Occupational Health for advice |
HG2 |
Carbapenemase Producing Enterobacteriaceae / organism (CPE) Including patients assessed as being HIGH RISK. Please refer to:- The Early Detection, Management and Control of Carbapenemase-Producing Enterobacteriaceae (CPE) guideline For Neonates please refer to Infections That Require Source Isolation on the Neonatal Unit Protocol Contact tracing and screening will need to be completed on those individuals that have had contact with the index case. |
Yes |
Person to person through direct contact with blood and body secretions from those infected or potentially colonised. Indirect contact from environmental surfaces, linen and patient care equipment that has been contaminated with infected blood or body fluids. |
Duration of admission |
Confirmed CPE positive - Enhanced Precautions- Long sleeved gowns and gloves High risk - |
HG2 |
CJD and vCJD Please refer to Note: “Danger of infection” labelling required w.r.t sample submissions: |
No |
The mode of transmission in conventional and sporadic CJD is unknown: Likelihood that direct contact with affected body fluids and tissue. Indirectly through medical equipment, for example surgical devices contaminated with body fluids or tissue. Care when managing contaminated equipment: please refer to policy |
N/A |
Source isolation precautions
Certain clinical procedures please refer to guidelines. (NB: Specific handling of surgical /other instruments may be required, depending on nature of risk & procedure being performed). |
HG3* Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Clostridium botulinum Foodborne, wound and intestinal botulism NOTIFIABLE DISEASE |
No |
Ingestion of contaminated foods which have been insufficiently heated to inactivate toxin/ destroy spores. Incubation -12-72 hours before neurological symptoms appear. |
N/A |
Standard Precautions |
HG2 |
Clostridium difficile Please refer to the guidelines: And Clostridium difficile Infection (CDI) in Adults (>16 years of age) For under 16 years please refer to:- Clostridium difficile infection (CDI) in children (<16 years of age) |
Yes |
Person to person through direct contact with faecal matter |
C. difficile likely present - source isolate until further results Toxin positive - for duration of hospital stay. Toxin negative but toxigenic strain present - for duration of hospital stay. If toxin negative & non-toxigenic strain: Source isolation can be discontinued |
Source Isolation Precautions Enhanced Precautions- Hand hygiene with soap and water Enhanced environmental & patient care equipment cleaning required. LTHT workers to contact Occupational Health |
HG2 |
Clostridium perfringens |
Yes |
Ingestion of contaminated foods that have been left to allow the organism to germinate and not cooked at the appropriate temperature |
Until 48 hrs symptom free |
Source Isolation Precautions LTHT workers to contact Occupational Health |
HG2 |
Corynebacterium ulcerans |
Yes |
Direct or indirect contact with a patient or carrier, contact with soiled articles that are contaminated with discharge fluids from lesions of infected people. In rare circumstances, milk has acted as a vehicle for transmission. Incubation is usually 3-5 days. |
Duration of admission |
Source Isolation Precautions
Enhanced precautions - Certain clinical procedures; please liaise with IPC Team on 22691 |
HG2 |
Cryptosporidium spp. |
Yes |
Faecal/ oral route which requires direct and / or indirect contact with faecal matter. The parasite can survive under adverse environmental conditions for long periods of time Incubation is variable between 1-12 days. The parasites that appear in the stools at the onset of symptoms are infectious immediately upon excretion. |
Until 48 hrs symptom free |
Source Isolation Precautions LTHT workers to contact Occupational health |
HG2 |
Diarrhoea +/- vomiting Please refer to Viral Gastroenteritis Clinical Guideline If specific infectious cause(s) identified, please refer to section for relevant organism(s) |
Yes |
From person to person by direct contact with airborne particles (vomit) and /or faecal matter. Indirectly through contaminated surfaces, linen and patient shared equipment. N.B. If viral gastro is suspected as a cause, this can be found in the stools of the affected person for up to 3 weeks |
Until 48 hours symptom free |
Source Isolation Precautions Enhanced Precautions Hand hygiene with soap and water LTHT workers to contact Occupational Health |
N/A |
Diphtheria All cases to be reported; If a case is suspected please contact IPC for advice.
|
Yes |
Rare but highly contagious. Person to person contact usually through respiratory droplets (coughing or sneezing) , In rare cases contact with soiled articles that are contaminated with discharge fluids from lesions of infected people. Incubation is usually 2-5 days. |
Until 2 cultures taken 24 hours apart are negative. |
Source Isolation Precautions Enhanced precautions: Surgical face mask LTHT workers to contact Occupational Health |
HG2 |
E. coli O157:H7 and other verotoxin-producing E. coli (e.g. E. coli O104:H4) NOTIFIABLE DISEASE Note: “Danger of infection” labelling required w.r.t sample submissions: |
Yes |
Ingestion of contaminated meat, foods and unpasteurised dairy products. This includes foods that are insufficiently cooked or prepared. Ingestion also occurs through contaminated drinking/ recreational water. Person to person contact with immediate family, childcare and other institutional facilities. Incubation 2-10 days. |
Until 48 hours symptom free |
Source Isolation Precautions LTHT workers to contact Occupational Health for advice. |
HG3* Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
ESBL (Extended Spectrum Beta-Lactamase producing) - Multi resistant organism Klebsiella spp Proteus spp For Neonates please refer to Infections That Require Source Isolation on the Neonatal Unit Protocol |
Yes |
Person to person through direct contact with blood and body secretions from those infected or potentially colonised. Indirect contact from environmental surfaces, linen and patient care equipment that has been contaminated with infected blood or body fluids. |
Duration of admission - and subsequent admissions |
Source Isolation Precautions |
HG2 |
Entamoeba histolytica |
No |
Parasitic infection - |
N/A |
Standard Precautions |
HG2 |
Giardia lamblia |
Yes |
Person to person via direct/ indirect contact of faecal matter of an infective person, contaminated drinking water or recreational water that may have been contaminated with faecal matter Incubation can be from 3-25 days. |
Until 48 hours symptom free |
Source Isolation Precaution |
HG2 |
Hepatitis A, E NOTIFIABLE DISEASE Note: “Danger of infection” labelling required w.r.t sample submissions: |
Yes |
Person to person direct / indirect contact with contaminated faecal matter or with water / food products contaminated by faeces. Indirectly from water and foods (either insufficiently prepared or previously cooked) contaminated by an infected person. |
Two weeks from onset of jaundice |
Source Isolation Precautions LTHT workers to contact Occupational Health. |
A = HG2 E = HG3* E: Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Hepatitis B, C, D NOTIFIABLE DISEASE Note: “Danger of infection” labelling required w.r.t sample submissions: |
No; unless actively haemorrhaging |
Through direct contact with blood and body fluids. This also includes sexual transmission. Indirectly through surfaces, linen and patient shared equipment contaminated by blood or body fluids. |
Only if active haemorrhaging |
Standard Precautions Enhanced Precautions- If waste contaminated with blood or body fluids (treat as clinical infectious waste) |
HG3* Note: “Danger of infection” labelling required w.r.t sample submissions: Please refer to appendix F |
Human immunodeficiency virus (HIV) Note: “Danger of infection” labelling required w.r.t sample submissions: |
No; unless actively haemorrhaging OR significant opportunistic infections and/ or if indicated by CD4 count. |
Person to person through unprotected sexual contact and other body secretions such as blood, CSF and Semen. Other types of body fluids-saliva, tears, urine; transmission has not been reported Indirectly through contact with contaminated needles and syringes; also through contaminated equipment such as surgical devices. |
No; unless actively haemorrhaging OR if significant opportunistic infection and/ or indicated by CD4 count |
Standard Precautions Enhanced Precautions - Certain clinical procedures; please liaise with IPC Team on 22691 |
HG3* Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Influenza Please see Respiratory Viruses - Guideline for the prevention of transmission |
Yes |
Predominately through airborne spread via droplet particles (coughs and sneezes) expelled by those that are infected. Indirectly through surfaces, linen and patient shared equipment contaminated by droplet particles. Incubation is around 2 days for seasonal influenza. The infected individual is most infectious for the first 3-5 days. In younger children this can be up to 7-10 days and longer for those who are immunocompromised |
See |
Source Isolation Precautions Enhanced Precautions- Surgical mask or FFP3 mask if undertaking aerosol generating procedures. |
HG2 |
Legionella spp. NOTIFIABLE DISEASE |
No |
Reservoir-aqueous environments, e.g. hot water systems, air conditioning, cooling towers, humidifiers, respiratory therapy devices. The organism has also been isolated from creeks, pond and soil from their banks. It can survive for months in distilled water |
No |
Standard Precautions |
HG2 |
Leprosy If a case is suspected please contact IPC NOTIFIABLE DISEASE Please see below for further information:- |
No |
Close contact with infected person. Predominately through airborne spread via respiratory secretion (coughs and sneezes) expelled by those that are infected. Exact mechanism of transmission is not truly understood. Incubation period can vary from between 3 and 10 years. |
NA |
Standard Precautions LTHT workers to contact Occupational Health. |
HG3 Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Leptospira interrogans |
Source isolation is not routinely required; Please contact IPC for further advice |
Direct contact with infected animal urine, fluids or tissue. Indirect exposure through water or soil (and in some countries foodstuffs) contaminated by urine from infected animals. Person-to-person transmission is rare. Symptoms usually develop 7-21 days after initial infection with leptospires, though rarely the incubation period can be as short as two to three days or as long as 30 days |
N/A |
Standard Precautions |
HG2 |
Listeria monocytogenes |
Source Isolation is not routinely required Please contact IPC for further advice |
Reservoir- Environmental sources include soil, forage, water, mud and silage. Unlike other food borne pathogens, Listeria tends to multiply in refrigerated foods that are contaminated Ingestion of raw or contaminated milk, soft cheeses, vegetables and ready to eat meats such as pate Incubation can vary form 3-70 days following exposure to an implicated product. |
Discuss with IPC |
Standard Precaution OR Source Isolation Precautions If isolation required LTHT workers to contact Occupational Health. |
HG2 |
Lyme disease |
No |
Infected ticks. The tick maybe attached for 24 hours before transmission. Incubation of 3-32 days after tick exposure (mean 7-10 days). |
N/A |
Standard Precautions |
HG2 |
Malaria NOTIFIABLE DISEASE
|
No |
The organism is usually transmitted by the bite of an infective Anopheles mosquito - (Vector) - with most species feeding at night Incubation time between infective bite and the appearance of clinical symptoms |
N/A |
Standard Precautions |
HG3* Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Measles If a case is suspected please contact IPC for advice. NOTIFIABLE DISEASE Please see below for further information:- |
Yes |
Airborne spread via droplet particles from infected individuals--nasal and respiratory secretions. Less commonly transmitted from articles that contain secretions. Incubation - from exposure to rash onset the average is 14 days with a range of 7 - 21 days. The person will be infectious 4 days prior to the onset of the rash to 4 days after the rash has developed. Those who are immunocompromised may be infectious for a greater length of time |
Until 4 full days after the rash appears. |
Source Isolation Precautions Enhanced Precautions- FFP3 mask if the patient is highly suspected or a known positive |
HG2 |
Neisseria meningitidis Meningococcal Meningitis and Septicaemia Please contact IPC for advice Refer to Public Health England Bacterial meningitis and meningococcal septicaemia in adults NOTIFIABLE DISEASE |
Yes; until 24 hrs appropriate antibiotics to eradicate bacteria from mouth and throat |
Airborne contact via droplet particles from respiratory and nasal secretions. Indirectly through surfaces, linen and patient shared equipment contaminated by blood or body fluids. 5%-10% of those infected have asymptomatic carriage. Less than 1% of those colonised will progress to invasive disease. |
Until patient has received 24 hours of appropriate treatment Any furtherquestion please contact IPC/ Microbiology. |
Source Isolation Precautions After 24 hours of appropriate treatment Antibiotic prophylaxis for staff who come into close contact with respiratory secretions (i.e. during resuscitation or intubation, without appropriate PPE) |
HG2 |
Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae, viruses and other organisms) Please contact IPC for advice or refer to Bacterial meningitis and meningococcal septicaemia in adults NOTIFIABLE DISEASE |
Yes For bacterial meningitis, prior to completion of 24 hrs appropriate antimicrobial treatment. H. influenzae; close contact requires prophylaxis |
Airborne contact via droplet particles from respiratory and nasal secretions. Pneumococcal –direct contact with an infected person would usually result in nasopharyngeal carriage rather than the disease. Indirectly through contaminated surfaces, linen and patient shared equipment. |
Until patient has received 24 hours of appropriate treatment. Any further question please contact IPC / Microbiology. |
Source Isolation Precautions After 24 hours of appropriate treatment |
HG2 |
Meticillin-resistant Staphylococcus aureus (MRSA) Please refer to |
Yes |
Person to person through direct contact with blood and body secretions from those infected or potentially colonised. Indirect contact from environmental surfaces, linen and patient shared equipment that has been contaminated with infected blood or body fluids. N.B. Airborne transmission poses significant risk if isolated in respiratory secretions. |
Evidence of 3 negative MRSA screens - see MRSA guideline for specific advice |
Source Isolation Precautions |
HG2 |
Middle East Respiratory Syndrome (MERS-CoV) Contact IPC / Infectious Diseases NOTIFIABLE DISEASE Please see :- |
Yes - placement into a negative pressure room is indicated as soon as possible. If not immediately available a neutral pressure room until it is, |
Primarily via droplets. |
Duration of admission |
Enhanced precautions:- Long sleeved gown, double gloves, FFP3 masks and visors |
HG3 Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “” labelling Danger of infection required w.r.t sample submissions: |
Multi-drug resistant |
Yes |
Direct contact with infected person. Indirect contact from surface areas, linen or patient shared equipment that has been contaminated by droplet particles/ saliva. |
For the duration of hospital admission |
Source Isolation Precautions |
HG2 |
Mumps If a case is suspected please contact IPC for advice. NOTIFIABLE DISEASE |
Yes |
Airborne via droplet particles from infected respiratory secretions or an infected person’s saliva. Direct contact with infective saliva. Indirect contact from surface areas, linen or patient shared equipment that has been contaminated by droplet particles/ saliva. Incubation period between 16 - 18 days |
9 days from onset of parotitis (swelling of the salivary glands) |
Source Isolation Precautions Enhanced Precautions- Surgical mask for close contact /airway management |
HG2 |
Poliomyelitis If a case is suspected please contact IPC NOTIFIABLE DISEASE |
Yes |
Primarily person to person through the faecal oral route or respiratory secretions Incubation can average 7-14 days from initial exposure with a range of 3 - 35 days. |
Duration of hospital admission |
Source Isolation Precaution
Enhanced Precautions- Respiratory precautions may be necessary in certain cases (please liaise with IPC for further advice). |
HG3 Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Panton-Valentine Leukocidin Staphylococcus aureus Please refer to And Public Health England - |
Yes |
Person to person through direct contact with blood and body secretions from those infected or potentially colonised. Indirect contact from environmental surfaces, linen and patient shared equipment that has been contaminated with infected blood or body fluids. N.B. Airborne transmission poses significant risk if isolated in respiratory secretions. |
For the duration of hospital admission. |
Source isolation precautions Enhanced Precautions - Certain clinical procedures; please liaise with IPC Team |
HG2 |
Pneumocystis jiroveci |
No Avoid placement of patient in the same room with an immunocomprosed patient. If patient is immunocompromised please contact IPC for isolation advice |
Transmission is unknown, potentially airborne |
N/A |
Standard Precautions |
N/A |
Rabies If a case is suspected please contact IPC for advice. NOTIFIABLE DISEASE Note: “Danger of infection” labelling required w.r.t sample submissions: |
No |
Virus laden saliva of a rabid animal introduced to the human through a bite or a scratch - usually from a dog Person to person transmission is theoretically possible, however this is rare. Incubation can be 3-8 weeks dependant of severity, wound site. Communicability is usually 3-7 days before the appearance of clinical symptoms and throughout infection. |
NA |
Standard Precautions Enhanced Precautions - Respiratory precautions may be necessary in certain cases (please liaise with IPC for further advice). |
HG3 (Rabies = HG3* Vesicular stomatitis virus= HG2) Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Rhinovirus spp
Please refer to For Neonates please refer to |
Yes |
Direct contact or inhalation of airborne droplets from an infected person, indirect contact with contaminated surfaces. Incubation is between 12 hours and 5 days; the usual period is on average 48 hours |
Until symptoms resolve. N.B. Cohorting of symptomatic patients can be undertaken with consultation of IPC Team. |
Source Isolation Precautions |
HG2 |
Rickettsia spp. Note: “Danger of infection” labelling required w.r.t sample submissions: |
No |
Reservoir- maintained in nature among ticks species; however the rickettsia can be found in dogs, various rodents and other animals found to be infected. Mode of transmission is usually through the bite (Vector) of an infected tick. The tick would need to attach for 4-6 hours before the organism becomes reactivated and infectious. Incubation is 2-21 days |
N/A |
Standard Precautions |
HG3 Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Rotavirus |
Yes |
Person to person contact through |
Until 48 hours symptom free |
Source Isolation Precaution LTHT workers to contact Occupational Health |
HG2 |
Respiratory Syncytial Virus (RSV) Please refer to Respiratory Viruses - Guideline for the prevention of transmission For neonates please refer to |
Yes |
Person to person through direct contact or inhalation of droplet particles (respiratory secretions). Indirectly through contaminated surfaces, linen and patient shared equipment. Contaminated hands carry virus to mucous membranes of the eyes and nose |
Until symptoms resolve. If symptoms are no longer present isolation can be discontinued 7 days after onset of illness. N.B. Cohorting of symptomatic patients can be undertaken with consultation of IPC Team. |
Source Isolation Precautions Enhanced Precautions- Masks to be used by staff entering the room whilst RSV nebuliser treatment being administered (please liaise with IPC for further advice). |
HG2 |
Rubella If a case is suspected please contact IPC for advice. NOTIFIABLE DISEASE |
Yes |
Person to person through direct contact or inhalation of droplet particles (nasopharyngeal secretions). Indirectly through contaminated surfaces, linen and patient shared equipment. N.B. Infants shed large quantities of the virus in their secretions and urine. Incubation period - 14-17 days with a range of 14-21 days Period of communicability - 1 week before - 4 days after appearance of rash |
1 week before - 4 days after appearance of rash |
Source Isolation Precaution |
HG2 |
Salmonella spp. If Salmonella typhi or Salmonella serovar:
Note: if suspecting typhoid / paratyphoid: “Danger of infection” labelling required w.r.t sample submissions: |
Yes |
Through ingestion of the organisms in foods derived from animals or contaminated by the faeces of infected animals/ persons. Person to person through direct contact with faeces. Indirectly through contaminated surfaces, linen or patient shared equipment. |
Until 48 hours symptom free |
Source Isolation Precaution LTHT workers to contact Occupational Health |
HG2 (paratyphi & typhi = HG3*) Note: if suspecting typhoid / paratyphoid: “Danger of infection” labelling required w.r.t sample submissions: |
Scabies Please refer to |
Yes |
Transfer of parasites occurs through prolonged direct contact with infested skin or sexual contact. Indirectly through immediate contact with bedclothes or undergarments contaminated by an infected person Risk of transmission is low; unless Norwegian scabies is suspected. |
A person is considered to be infectious from the time of infestation until treatment is completed
|
Source Isolation Precaution Enhanced Precaution- Long sleeved gowns during the patients shower and treatment application should be worn. Cuffs of the gowns should go under the gloves. |
N/A |
Severe Acute Respiratory Syndrome If a case is suspected please contact IPC for advice. NOTIFIABLE DISEASE |
Yes |
Primarily via droplets. Incubation is 2-10 days Communicability is still not fully understood, However, evidence has suggested that infectivity does not commence until symptoms are event and for no greater than 21 day from onset. |
Duration of Symptoms |
Source Isolation Precaution Enhanced Precautions- Surgical mask or N.B: Enhanced precautions required in immuno-compromised patients’ will require appropriately ventilated side room (Contact IPC ). |
HG3* Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Shigella spp. |
Yes |
Direct/ indirect contact via the faecal oral route from symptomatic infective or asymptomatic carrier. Incubation is around 1-3 days Communicability is at the onset of symptoms and can persist for a period of greater than 4 weeks. |
Until symptom free for 48 hours or the organism is no longer detected in the faeces. |
Source Isolation Precaution LTHT workers to contact Occupational Health |
HG2 (Shigella dysenteriae (Type 1) = HG3*) Note: if suspecting Shigella dysenteriae: “Danger of infection” labelling required w.r.t sample submissions: |
Tetanus NOTIFIABLE DISEASE |
No |
Tetanus spores are usually introduced into the body via open wounds that come into contact with contaminated soil, street dust, or animal or human faeces. |
N/A |
Standard Precautions |
HG2 |
Group A Streptococcal (Streptococcus pyogenes) Infection (scarlet fever and some cases of impetigo and erysipelas) Please refer to LTHT IPC Group A Streptococcal Infections ( GAS ) Guideline NOTIFIABLE DISEASE |
Yes |
Respiratory secretions Indirectly through contaminated surfaces, linen or patient shared equipment. Incubation is normally 1-3 days. In untreated, uncomplicated cases the person can potentially be infectious for 7-21 days. In cases where there is a purulent discharge the person has the potential to be infectious for months. |
Until 24 hours of appropriate antimicrobial treatment is completed. Some patients should remain source isolated for longer- Cases of necrotising fasciitis; Mothers and neonates on maternity units; Invasive Group A Streptococcal infection - source isolation may be extended for longer. IPC advice should be sought in these cases. |
Source Isolation Precaution Enhanced Precaution |
HG2 |
Pneumococcal Pneumonia (Streptococcus pneumoniae) |
No NB: if resistant strain or clinical area has severely immune-compromised patients, source isolation may be required. |
Airborne contact via droplet particles from respiratory and nasal secretions. Indirectly through surfaces, linen and patient care equipment contaminated by blood or body fluids. Incubation- usually 1-3 days |
N/A . |
Standard Precautions To liaise with IPC if source isolation required. |
HG2 |
Tuberculosis Pulmonary Tuberculosis NOTIFIABLE DISEASE Also refer to Tuberculosis (Including Multi drug and Extensively Drug Resistant Tuberculosis) Note: “Danger of infection” labelling required w.r.t sample submissions: |
Yes |
Airborne via respiratory droplet or direct contact with droplet particles (sneezing/ coughing) of those infected.
|
Until at least 2 weeks of anti-TB treatment has been completed N.B. A risk assessment must be completed by clinicians prior to removing isolation precautions |
Standard precautions ( Negative pressure ventilation preferable. |
HG3 Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Multi Drug Resistant (MDR) / Extremely Drug Resistant (XDR) For all suspected or confirmed cases please contact IPC for advice. NOTIFIABLE DISEASE Also refer to Tuberculosis (Including Multi drug and Extensively Drug Resistant Tuberculosis) Note: “Danger of infection” labelling required w.r.t sample submissions: |
Yes |
Airborne via respiratory droplet or direct contact with droplet particles (sneezing/ coughing) of those infected. |
Liaise with the supervising physician in conjunction with Microbiology/ IPC Team. |
Source Isolation Precaution
Enhanced precautions: |
HG3 Samples must be hand delivered and clearly document the hazard group category in the clinical details field Note: “Danger of infection” labelling required w.r.t sample submissions: |
Extra Pulmonary Tuberculosis
|
No |
No Spread |
NA |
Standard Precautions Enhanced precautions if aerosolising procedures are being under taken or draining wounds |
HG3 Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Latent Tuberculosis |
No |
Non Infectious |
NA |
Standard Precautions |
HG3 Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Vancomycin Resistant Enterococcus - VRE Please refer to
|
Yes |
Person to person through direct contact with blood and body secretions from those infected or potentially colonised. Indirect contact from environmental surfaces, linen and patient care equipment that has been contaminated with infected blood or body fluids. VRE is not usually spread through the air by cough or sneezing. |
Duration of admission |
Source Isolation Precaution |
HG2 |
Varicella zoster virus (VZV) In all suspected or confirmed cases please contact IPC. Refer to Chickenpox-Shingles (Varicella-Zoster Virus Infections) : Prevention And Control |
Yes |
Person to person by direct contact with droplet particles or airborne spread of vesicle fluid or respiratory secretions Indirectly through contaminated equipment, linen and environmental surfaces that have had contact with vesicle fluid and secretions. Chicken pox has an incubation period of around 10- 21 days (usually 10-14 days). The infected individual is infectious to others 2 days prior to the development of the rash. |
Until crusting and drying of all lesions has occurred N.B. Isolation maybe required for a longer period if patients are immuno-compromised. |
Source Isolation Precaution Enhanced Precautions - |
HG2 |
Cholera (Vibrio cholerae ) NOTIFIABLE DISEASE
|
Yes in severe illness |
Reservoir Humans Ingestion of faecally contaminated water or shellfish and other foods |
Duration of illness in severe cases |
Source Isolation Precaution in severe illness Discuss all suspected or confirmed cases with IPC LTHT workers to contact Occupational Health. |
HG2 |
Viral Gastroenteritis Please refer to LTHT IPC Viral Gastroenteritis guidelines Viral Gastroenteritis Clinical Guidelines Also refer C.difficile Guidance if either are suspected. Clostridium Difficile Infection ( CDI ) in Adults ( >16 years of age ) |
Yes |
Contact via faecal oral route Average incubation period is between 24-48 hours. N.B. If viral gastro is suspected as a cause, this can be found in the stools of the affected person for up to 3 weeks |
Until 48 hours symptom free |
Source Isolation Precaution
Enhanced precautions: LTHT workers to contact Occupational Health. |
HG2 |
Viral Haemorrhagic Fevers These include the Ebola, Marburg, Lassa fever, and yellow fever viruses, Crimean-Congo Haemorrhagic fever virus In all suspected or confirmed cases please contact IPC immediately. NB: please see Appendix F prior to submitting sample(s) Also refer to Managing patients who require assessment for Ebola virus disease |
Yes N.B. Please consult/ discuss all cases with IPC |
Person to person through direct contact with symptomatic patient or contaminated blood and body fluids. Indirectly through contact with contaminated surfaces, linen and patient shared equipment. The risk of transmission increases significantly in the latter stages of the infection due to excretion through body fluids (vomit, diarrhoea and haemorrhaging). |
As advised by IPC |
Please contact IPC immediately as patient will require Specialised Isolation in Bio-safety facility. Enhanced precautions: |
HG4 - contact microbiology consultant for further guidance HG3 - Yellow Fever, Samples must be hand delivered and clearly document the hazard group category in the clinical details field. Note: “Danger of infection” labelling required w.r.t sample submissions: |
Whooping cough NOTIFIABLE DISEASE All cases to be reported; Please refer to Pertussis (Whooping Cough) and |
Yes |
Direct contact from respiratory secretions (coughing, sneezing, respiratory procedures) Incubation period is average 9-10 days (range 6-20) Highly infectious in the first 2 weeks.5 |
Until the patient has received 48 hours of appropriate antibiotic treatment OR 21 days from onset of symptoms if no appropriate antibiotic therapy has been received Source isolation for immuno-compromised patients will need to be for the duration of their admission. |
Source Isolation Precaution Enhanced precautions: LTHT workers to contact Occupational Health |
HG2 |
|
Provenance
Record: | 1671 |
Objective: | |
Clinical condition: | |
Target patient group: | All patients in LTHT |
Target professional group(s): | Secondary Care Doctors Secondary Care Nurses |
Adapted from: |
Evidence base
References
Centre for Disease Control and Prevention (CDC) (2007): Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Available at: https://www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines.pdf
Department of Health (2011). Health Protection Agency and Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections, Advice on Carbapenemase Producers: Recognition, infection control and treatment
Health Protection Agency (2012). Guidance for public health management of meningococcal disease in the UK.
Health Protection Agency. Investigation into multi-drug resistant ESBL producing Escherichia coli strains causing infections in England
http://www.hpa.org.uk/hpa/publications/esbl_report_05/
Health Protection Agency (2008). Guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England. Available at: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1218699411960
Heymann D, (ED) (2015) Control of Communicable Diseases Manual, 20th Edition, American Public Health Association
Public Health England (2013). Interim Guidance for the Control of Carbapenemasse-Producing Enterobacteriaceae in England: Advice for NHS Boards and Health Professionals in the Public and Independence Sector (DRAFT). Available at:
http://www.rcn.org.uk/__data/assets/pdf_file/0007/503458/Draft_Interim_CPE_Guidance_7_Feb_2013.pdf
Public Heath England (2012). Memorantum on leprosy 2012 on behalf of the Panel of Leprosy Opinion.
Public Health England (2016). PHE Guidelines for the Public Health Management of Pertussis Incidents in Healthcare Settings. Available at:
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/564657/Guidelines_for_the_
Public_Health_Management_of_Pertussis_in_Healthcare_Settings_2016.pdf
Public Health England (2017). PHE National Measles guidelines. Available at:
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/637338/PHE_Measles_guidance
_August_2017.pdf
Public Health Department (2010). The Health Protection (Notification) Regulations. Available at:
http://www.opsi.gov.uk/si/si2010/uksi_20100659_en_1
US Department of Health and Human Services. Bacillus cereus. Available at: www.foodsafety.gov/poisoning/causes/bacteriaviruses/bcereus/index.html
Working party guidance on the control of multi-resistant Acinetobacter outbreaks
http://www.hpa.org.uk/infections/topics_az/acinetobacter_b/guidance.htm
Evidence levels:
A. Meta-analyses, randomised controlled trials/systematic reviews of RCTs
B. Robust experimental or observational studies
C. Expert consensus.
D. Leeds consensus. (where no national guidance exists or there is wide disagreement with a level C recommendation or where national guidance documents contradict each other)
Approved By
Trust Clinical Guidelines Group
Document history
LHP version 2.0
Related information
Appendix A - Definitions
ß-lactamase. Bacterial enzymes that inactivate β-lactam antibiotics (penicillins and cephalosporins) and therefore cause resistance to these antibiotics.
Carbapenemase. Bacterial enzyme that inactivates carbapenems (e.g. meropenem), which are very broad-spectrum “last line” antibiotics.
Colonisation. The presence, growth and multiplication of an organism at a body site without observable clinical symptoms.
Extended spectrum ß-lactamases (ESBL). Bacterial enzymes produced by MRGNB (see below) that inactivate multiple β-lactam antibiotics.
Fomite. Inanimate object that can act as an intermediate reservoir for the transmission of micro-organisms. Fomites include mobile items (stethoscopes, ultrasound probes etc.) and fixed items (door handles, telephones).
Gram-negative bacilli (GNB).Organisms that are commonly found in the gastro-intestinal tract, water and soil.
Multi-resistant GNB (MRGNB). GNB that are resistant to multiple antibiotics or antibiotic classes. Common MRGNB include Klebsiella spp., Pseudomonas spp., Enterobacter spp. and Acinetobacter spp. (Please see appendix D).
Source isolation. Physical separation of a patient within a single side room or similar cohort facility to reduce the risk of transmission of infection
Transmissible infection. Infection that can be communicated from a patient to another person (patient, member of staff or visitor).
Vector. Human or animal (including insect) that can act as an intermediate reservoir for the transmission of micro-organisms. In the hospital setting vectors are usually staff, patients or visitors.
Appendix B - List of Other Organisms/Conditions That Pose a Risk to other in-patients at LTHT
If a case is suspected please contact IPC for advice.
Chikungunya Virus |
Note: Please also refer to Appendix G if the above organisms is suspected for danger of infection samples
Appendix C - List of Groups Posing a Special Risk of Spreading Gastro-intestinal Infections
Those identified in risk groups 1 and 2 please contact Infection Prevention and Control for advice For those in risk groups 3 and 4, assume that once they have passed a normal stool, and they can practice hand hygiene under supervision, they may no longer require exclusion. Please risk assess each case individually, and if you remain unsure, please contact the Infection Prevention and Control Team. N.B. For further guidance please refer to LTHT Food Safety policy |
Appendix D - Multi Drug Resistant Micro-organisms
This criterion will ONLY apply to Enterobacteriaceae (e.g. ‘coliforms’), P. aeruginosa and Acinetobacter spp (predominantly A. baumannii).
The need to source isolate patients with other multi-resistant Gram negative organisms will be determined on a case-by-case basis on the advice of a consultant medical microbiologist.
All ESBL-positive and all carbapenemase-positive examples of the above.
For organisms that are ESBL and carbapenemase-negative, those that are resistant to two or more of the following classes of antibiotics:
-
- Broad-spectum beta lactams (defined as piperacillin-tazobactam, third generation cephalosporins, aztreonam, meropenem, Imipenem/ ertapenem)
- Quinolones
- Aminoglycosides
In addition any patient harbouring colistin-resistant P. aeruginosa, Acinetobacter spp or Enterobacteriaceae (excluding Serratia spp and Proteus spp which are inherently colistin-resistant) should also be source isolated.
Appendix E - Communicable Notifiable Diseases
Registered Medical Practitioners attending a patient with a known or suspected notifiable disease must notify the local authority (Public Health England):
Has a notifable disease as listed below of the Notifications Regulations or
Has an infection not included in the list below which in the view of the practitioner presents, or could present, significant harm to human health; e.g. emerging or new infections; or
Is contaminated, such as with chemical or radiation, in a manner which, in view of the practitioner presents, or could present, significant harm to human health; or
Has died with, but not necessarily because of a Notifiable disease, or other infectious disease or contamination that presents, or could present, or that presented or could have presented significant harm to human health
NOTE: Notification of cases of infection not included in Schedule 1 and of contamination are expected to be exceptional occurrences.
NOTE: Practitioners should not wait for laboratory confirmation or results of other investigations in order to notify a case
Schedule 1 Diseases
Acute encephalitis |
Measles |
For further information refer to Department of Health Protection Legislation (England) Guidance 2010 Notifiable diseases and causative organisms: how to report - GOV.UK
Appendix F - Danger of Infection Samples
Standards for the Labelling of Request Cards and Specimens for Pathology Investigation
https://leedspath.myeqms.com
Reason for labelling
To comply with National Health and Safety guidance and to alert laboratory staff that the specimen may require processing differently.
What is a “high risk” (Danger of Infection) specimen?
Clinical judgment must be used to label specimens correctly, and the onus for this is on the requestor. Specimens from the following MUST have a “Danger of Infection” label:
- patients with proven infection with a Hazard Group 3 (HG3) pathogen (see list below)) e.g. hepatitis B and C, HIV, tuberculosis and other mycobacteria, typhoid, brucella and anthrax
- A patient who is part of an on-going outbreak caused by a HG3 pathogen.
- Patients suspected of having a HG3 pathogen (information from clinical history and examination - see table below for clinical details that increase risk of isolating HG3 pathogens)
Clinical Detail |
High Risk Occupations |
High Risk Sports/Pastimes |
IVDA |
Hospital or Laboratory staff (exposure incident) |
Outdoor Water Sports |
Return travel/visitor from abroad where HG3 pathogens are endemic* |
Veterinary / Animal worker |
Caving / pot-holing |
Consumption of unpasteurised products (milk/diary) |
Farming, visit to farm |
Camping & Hunting in endemic areas* |
Psoas abscess / cold abscess |
Slaughter house/abbatoir worker/butcher |
Animal Hide Drum playing/making |
Enteric fever |
Horse caretakers |
|
HUS - (haemolytic uremic syndrome) |
Equine Butchers |
|
Consumption of raw or undercooked meat products |
Industrial processing of wool, hide or hair |
|
Prison Inmates |
Meat Packing Plant Employees |
|
Haemophilliac |
|
|
vCJD |
|
|
*Endemic areas differ depending on the pathogen but can include European countries for some infections. If unsure what the infection may be caused by include all travel details and the laboratory will assess the risk
If there is doubt as to whether a specimen is “high risk”, please contact the microbiology laboratory. On no account should specimens be taken from patients suspected of having any pathogen in Hazard Group 4, e.g. viral haemorrhagic fever (Lassa, Marburg, Ebola and Congo Crimean), or Hendra or Nipah viruses without prior consultation with the on-call medical microbiologist/virologist.
Handling “Danger of Infection” specimens
“Danger of Infection” labels should have black print on a yellow background, and should be self-adhesive. A label MUST be placed on the high-risk specimen container and its request form, which must give sufficient clinical information to enable the experienced laboratory staff to know what special precautions are necessary in the laboratory. Writing “Danger of Infection” is not adequate and can easily be missed. The request form may be folded so that the information need not be conspicuous to other people, but the “Danger of Infection” label must be clearly visible.
The specimen container must be placed in an individual transparent plastic bag, which should then be sealed. The specimen should then be transported by the usual system.
Danger of Infection Labels can be obtained from the print unit – Code WRN502
Specimens from patients known or suspected to be suffering from the following clinical conditions/micro-organisms must have “Danger of Infection” labels on both specimen and request form. This list is not exhaustive.
Bacteria
Anthrax (Bacillus anthracis)
Bacillary dysentery (Shigella dysenteriae type 1)
Brucellosis (Brucella species)
Ehrlichiosis (Ehrlichia species)
E. coli O157/VTEC
Glanders/Meliodosis (Burkholderia/Pseudomonas mallei and pseudomallei)
Plague (Yersinia pestis)
Q fever (Coxiella burnetti)
Rickettsia species
Tuberculosis and Mycobacterium species
Tularaemia (Francisella tularensis)
Typhoid and paratyphoid (Salmonella typhi and paratyphi)
Viruses
Dengue
Hantaviruses
Hepatitis (unknown cause, hepatitis B, C, D, E and G)
HIV/HTLV
Rabies
Yellow fever
Any pyrexial returning traveller (from non viral haemorrhagic fever area)
Also Transmissible spongiform encephalopathies (CJD, vCJD etc)
Parasites
Echinococcus species
Leishmania species
Falciparum malaria (Plasmodium falciparum)
Naegleria species
Pork tapeworm (Taenia solium)
Sleeping sickness (Trypanosoma species)
Fungi
Blastomyces dermatitidis
Cladophialophora bantana
Coccidioides immitis
Histoplasma species
Paracoccidioides brasiliensis
Penicillium marneffei
Equity and Diversity
The Leeds Teaching Hospitals NHS Trust is committed to ensuring that the way that we provide services and the way we recruit and treat staff reflects individual needs, promotes equality and does not discriminate unfairly against any particular individual or group.